According to estimates, the point-of-care cholesterol monitoring devices market share would be valued US$ 514.7 million by 2028, up from US$ 428.8 million in 2021. In 2021, the market for point-of-care cholesterol monitoring devices is expected to reach US$ 428.8 million, with a year-over-year revenue growth of slightly less than 2.6%, according to a recent …